A child, 10 years old, complaints of headache, an increase in body temperature 10 36.8 "C. hemorrhagic rashes on the shins, thighs, buttocks, swelling of the knee and ankle joints. soreness when moving. It is known from the history of the disease that 3 weeks ago he was ill with ARVI, his mother gave paracetamol to reduce the temperature. Against the background of taking medications, a fine-spotted rash appeared on the skin of the shins, swelling of the knee joints, soreness in them when moving. A pediatrician called from the polyclinic regarded the symptoms as an allergic reaction to drug therapy. The patient was advised to stop taking anti-inflammatory drugs. Antihistamines are prescribed. After 2-3 days, the rashes and swelling of the joints disappeared, arthralgia stopped. In dynamics, the condition worsened again: hemorrhagic rashes appeared on the lower extremities, thighs, buttocks, swelling and soreness in the knee and ankle joints when moving. headache and weakness increased. Objectively: the patient's condition is moderate, the body temperature is 36,8 °C. The skin is pale, dry. On the skin of the extensor surfaces of the feet, shins, thighs, hemorrhagic rashes, sometimes having a drain character. The knee and ankle joints are enlarged in volume, movements in them are painful. Acute cramping pain in the abdomen every 5-7 minutes, during which the patient rushes and moans. In the lungs, respiration is vesicular, BH-20 per minute. The boundaries of the heart are within the normal range, the tones are muted, tachycardia is 100 per minute, the rhythm is correct, blood pressure is 100/60 mm Hg. Data from laboratory research methods. Clinical blood test: Hb-90 g/l, leukocytes-12.6 x109/1, rod-shaped 12%, 3.23. ESR-34 mm/h, platelets-180x109/1. Clinical analysis of urine: relative density-1015, protein-0.33 mg/l, red blood cells-0-1 in the field of vision.

Reading File
Finding Sources
Finding Sources
Searching PubMed

Henoch-Schonlein purpura children treatment

Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Searching Images

Henoch-Schonlein purpura rash legs child

I now have comprehensive information to provide a thorough clinical analysis. Let me compile the full answer.

Clinical Analysis: IgA Vasculitis (Henoch-Schönlein Purpura)

Diagnosis

IgA Vasculitis (IgAV) — formerly Henoch-Schönlein Purpura (HSP)
This is the unifying diagnosis. The case fulfills the EULAR classification criteria: mandatory criterion of palpable purpura on the lower limbs PLUS multiple supporting criteria:
  • Acute cramping abdominal pain
  • Acute arthralgia/arthritis (knees and ankles)
  • Proteinuria + microscopic hematuria (renal involvement)
Tietz Textbook of Laboratory Medicine, 7th Edition

Pathophysiology

IgAV is a small-vessel vasculitis driven by abnormal IgA1 glycosylation (galactose-deficient IgA1). This creates neoepitopes, triggering IgG anti-IgA antibody production → IgA1-containing immune complexes → deposition in small vessel walls → leukocytoclastic vasculitis and systemic inflammation.
Triggering event in this child: ARVI (upper respiratory viral infection) 3 weeks prior — the classic precipitant (viral infection or streptococcal pharyngitis precedes ~50% of cases). The initial "drug allergy" diagnosis was incorrect; the fine-spotted rash and joint swelling after ARVI were the first manifestation of IgAV.
Andrews' Diseases of the Skin

Clinical Features — Correlation with This Case

FeatureThis PatientTypical IgAV
Age10 yearsPeak 2–8 yrs; 75% in children
Triggering eventARVI 3 weeks agoViral/streptococcal infection
Hemorrhagic purpura on shins, thighs, buttocksPresent in >95%
Joint swelling (knee + ankle)63–85% of patients
Cramping abdominal pain (q 5–7 min)~65%
Low-grade fever, headacheCommon prodrome
Relapsing course~30% have recurrent disease
The bilateral joint involvement and absence of high fever help distinguish this from septic arthritis. The initial resolution after stopping paracetamol (and starting antihistamines) was a spontaneous remission — not an antihistamine response.

Laboratory Interpretation

TestResultInterpretation
Hb 90 g/LLowMild anemia — likely from GI blood loss and/or inflammation
Leukocytes 12.6 × 10⁹/L, rods 12%Elevated with left shiftActive inflammatory response
ESR 34 mm/hElevatedOngoing systemic inflammation
Platelets 180 × 10⁹/LNormalKey finding: rules out ITP and TTP/HUS
Urine protein 0.33 mg/LMild proteinuriaEarly renal involvement
Urine RBC 0–1/hpfNear normalMicroscopic hematuria
Critical point: Normal platelet count distinguishes IgAV from immune thrombocytopenic purpura (ITP), thrombotic thrombocytopenic purpura (TTP), and hemolytic-uremic syndrome (HUS) — all of which cause thrombocytopenia with purpura.
Tintinalli's Emergency Medicine

Typical Rash

IgA vasculitis purpura on lower extremity, pediatric patient showing non-blanching palpable purpura
Classic non-blanching palpable purpura on lower extremities in pediatric IgAV
Progression from petechiae to confluent purpura in HSP
Panels showing distribution from feet/ankles (day 1) extending to thighs — identical distribution to this patient

Differential Diagnosis to Exclude

ConditionReason to Exclude
ITPPlatelet count normal (180 × 10⁹/L)
Septic arthritisBilateral joint involvement, no extreme fever
MeningococcemiaNo septic shock, non-blanching pattern on dependent areas
Drug reaction (initial misdiagnosis)Relapsing course, classic tetrad present
HUSNo thrombocytopenia, no microangiopathic hemolytic anemia

Management

1. Hospitalization — indicated given:
  • Severe cramping abdominal pain (risk of intussusception, GI bleeding)
  • Moderate condition with tachycardia and anemia
  • Renal involvement (proteinuria)
2. Supportive care — the disease is typically self-limited (6–16 weeks). No single therapy shortens this duration.
3. Abdominal painCorticosteroids (prednisone 1 mg/kg/day) are more effective than analgesia for abdominal pain; also attenuate joint symptoms. Use for 2 weeks then taper over 2 weeks.
  • An H2 blocker (ranitidine/famotidine) may be co-administered for GI symptoms.
4. Joint symptoms — NSAIDs are effective for arthralgia, but use with caution given this child has renal involvement (proteinuria) — NSAIDs may worsen renal function.
5. Renal monitoring — mild proteinuria present; follow-up urinalysis and blood pressure at every visit for at least 6 months. Corticosteroids may be used preventively or to treat active nephritis, though randomized trials have not confirmed long-term renal benefit.
6. Severe/refractory cases — IVIG for refractory skin/abdominal disease; cyclophosphamide or azathioprine for severe nephritis.
Avoid — antihistamines (ineffective; the initial treatment error in this case).
Andrews' Diseases of the Skin; Tintinalli's Emergency Medicine

Prognosis

  • Overall favorable; most children recover fully within 6–16 weeks
  • Relapses occur in ~30% — this child is already on his second episode
  • Long-term renal insufficiency develops in <8% of children
  • Risk factors for worse renal outcome: persistent proteinuria >1 g/day, gross hematuria, hypertension
  • Regular follow-up urinalysis essential for 6–12 months

Recent Evidence (PubMed, 2024–2025)

For children who develop nephritis (which this child shows early signs of with proteinuria):
  • A 2024 meta-analysis (PMID: 39058868) compared mycophenolate mofetil vs. cyclophosphamide in IgAV nephritis — both options for steroid-refractory nephritis
  • A 2024 systematic review (PMID: 39249581) examined rituximab for IgAV nephritis in refractory disease
These apply if nephritis progresses beyond the current mild proteinuria.

Summary: This 10-year-old has IgA Vasculitis (HSP) — a post-viral immune complex small-vessel vasculitis with the classic tetrad of palpable purpura (lower limbs/buttocks), arthritis (knees/ankles), abdominal colic, and early renal involvement. The initial misdiagnosis as drug allergy delayed recognition. Management now centers on hospitalization, corticosteroids for abdominal pain, and close renal surveillance.
This is a shared conversation. Sign in to Orris to start your own chat.